Cargando…
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387307/ https://www.ncbi.nlm.nih.gov/pubmed/32047238 http://dx.doi.org/10.1038/s41375-020-0735-y |
| _version_ | 1783564093865590784 |
|---|---|
| author | Rambaldi, Alessandro Iurlo, Alessandra Vannucchi, Alessandro M. Noble, Richard von Bubnoff, Nikolas Guarini, Attilio Martino, Bruno Pezzutto, Antonio Carli, Giuseppe De Muro, Marianna Luciani, Stefania McMullin, Mary Frances Cambier, Nathalie Marolleau, Jean-Pierre Mesa, Ruben A. Tibes, Raoul Pancrazzi, Alessandro Gesullo, Francesca Bettica, Paolo Manzoni, Sara Di Tollo, Silvia |
| author_facet | Rambaldi, Alessandro Iurlo, Alessandra Vannucchi, Alessandro M. Noble, Richard von Bubnoff, Nikolas Guarini, Attilio Martino, Bruno Pezzutto, Antonio Carli, Giuseppe De Muro, Marianna Luciani, Stefania McMullin, Mary Frances Cambier, Nathalie Marolleau, Jean-Pierre Mesa, Ruben A. Tibes, Raoul Pancrazzi, Alessandro Gesullo, Francesca Bettica, Paolo Manzoni, Sara Di Tollo, Silvia |
| author_sort | Rambaldi, Alessandro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7387307 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73873072020-08-11 Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study Rambaldi, Alessandro Iurlo, Alessandra Vannucchi, Alessandro M. Noble, Richard von Bubnoff, Nikolas Guarini, Attilio Martino, Bruno Pezzutto, Antonio Carli, Giuseppe De Muro, Marianna Luciani, Stefania McMullin, Mary Frances Cambier, Nathalie Marolleau, Jean-Pierre Mesa, Ruben A. Tibes, Raoul Pancrazzi, Alessandro Gesullo, Francesca Bettica, Paolo Manzoni, Sara Di Tollo, Silvia Leukemia Letter Nature Publishing Group UK 2020-02-11 2020 /pmc/articles/PMC7387307/ /pubmed/32047238 http://dx.doi.org/10.1038/s41375-020-0735-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Rambaldi, Alessandro Iurlo, Alessandra Vannucchi, Alessandro M. Noble, Richard von Bubnoff, Nikolas Guarini, Attilio Martino, Bruno Pezzutto, Antonio Carli, Giuseppe De Muro, Marianna Luciani, Stefania McMullin, Mary Frances Cambier, Nathalie Marolleau, Jean-Pierre Mesa, Ruben A. Tibes, Raoul Pancrazzi, Alessandro Gesullo, Francesca Bettica, Paolo Manzoni, Sara Di Tollo, Silvia Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study |
| title | Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study |
| title_full | Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study |
| title_fullStr | Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study |
| title_full_unstemmed | Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study |
| title_short | Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study |
| title_sort | safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part phase ib/ii study |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387307/ https://www.ncbi.nlm.nih.gov/pubmed/32047238 http://dx.doi.org/10.1038/s41375-020-0735-y |
| work_keys_str_mv | AT rambaldialessandro safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT iurloalessandra safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT vannucchialessandrom safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT noblerichard safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT vonbubnoffnikolas safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT guariniattilio safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT martinobruno safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT pezzuttoantonio safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT carligiuseppe safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT demuromarianna safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT lucianistefania safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT mcmullinmaryfrances safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT cambiernathalie safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT marolleaujeanpierre safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT mesarubena safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT tibesraoul safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT pancrazzialessandro safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT gesullofrancesca safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT betticapaolo safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT manzonisara safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy AT ditollosilvia safetyandefficacyofthemaximumtolerateddoseofgivinostatinpolycythemiaveraatwopartphaseibiistudy |